Cargando…

Influence of the Hypersensitivity to Low Dose Phenomenon on the Tumor Response to Hypofractionated Stereotactic Body Radiation Therapy

SIMPLE SUMMARY: We demonstrated the possible occurrence of the hypersensitivity to low dose (HRS) phenomenon in SBRT modality in both tumor and healthy cells. In HRS-positive cells, the response to SBRT was found exacerbated. Notably, a subset of highly damaged cells can appear and increase the effi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Le Reun, Eymeric, Granzotto, Adeline, Pêtre, Adeline, Bodgi, Larry, Beldjoudi, Guillaume, Lacornerie, Thomas, Vallet, Véronique, Bouchet, Audrey, Al-Choboq, Joëlle, Bourguignon, Michel, Thariat, Juliette, Bourhis, Jean, Lartigau, Eric, Foray, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416967/ https://www.ncbi.nlm.nih.gov/pubmed/37568795 http://dx.doi.org/10.3390/cancers15153979

Ejemplares similares

Quantitative Correlations between Radiosensitivity Biomarkers Show That the ATM Protein Kinase Is Strongly Involved in the Radiotoxicities Observed after Radiotherapy
por: Le Reun, Eymeric, et al.
Publicado: (2022)

Cancer and Radiosensitivity Syndromes: Is Impaired Nuclear ATM Kinase Activity the Primum Movens?
por: El Nachef, Laura, et al.
Publicado: (2022)

X-rays-Induced Bystander Effect Consists in the Formation of DNA Breaks in a Calcium-Dependent Manner: Influence of the Experimental Procedure and the Individual Factor
por: Restier-Verlet, Juliette, et al.
Publicado: (2023)

Toward an Early Diagnosis for Alzheimer’s Disease Based on the Perinuclear Localization of the ATM Protein
por: Berthel, Elise, et al.
Publicado: (2023)

Radiation on Earth or in Space: What Does It Change?
por: Restier-Verlet, Juliette, et al.
Publicado: (2021)

The Radiobiological Characterization of Human and Porcine Lens Cells Suggests the Importance of the ATM Kinase in Radiation-Induced Cataractogenesis
por: Al-Choboq, Joëlle, et al.
Publicado: (2023)

Human Radiosensitivity and Radiosusceptibility: What Are the Differences?
por: El-Nachef, Laura, et al.
Publicado: (2021)

Low-Dose Radiation Therapy (LDRT) against Cancer and Inflammatory or Degenerative Diseases: Three Parallel Stories with a Common Molecular Mechanism Involving the Nucleoshuttling of the ATM Protein?
por: Le Reun, Eymeric, et al.
Publicado: (2023)

Molecular Influence of the ATM Protein in the Treatment of Human Cells with Different Radioprotective Drugs: Comparisons between Antioxidative and Pro-Episkevic Strategies
por: Restier-Verlet, Juliette, et al.
Publicado: (2023)

Usher Syndrome Belongs to the Genetic Diseases Associated with Radiosensitivity: Influence of the ATM Protein Kinase
por: Al-Choboq, Joëlle, et al.
Publicado: (2022)

Hypofractionated Stereotactic Radiotherapy for Patients with Intracranial Meningiomas: impact of radiotherapy regimen on local control
por: Meniai-Merzouki, F., et al.
Publicado: (2018)

Vestibular Schwannoma: Results of Hypofractionated Stereotactic Radiation Therapy
por: Pialat, Pierre-Marie, et al.
Publicado: (2021)

Hypofractionated stereotactic boost in intermediate risk prostate carcinoma: Preliminary results of a multicenter phase II trial (CKNO-PRO)
por: Pasquier, David, et al.
Publicado: (2017)

DNA Double-Strand Breaks Induced in Human Cells by Twelve Metallic Species: Quantitative Inter-Comparisons and Influence of the ATM Protein
por: Viau, Muriel, et al.
Publicado: (2021)

Diffusion weighted MRI as an early predictor of tumor response to hypofractionated stereotactic boost for prostate cancer
por: Pasquier, David, et al.
Publicado: (2018)

DNA Double-Strand Breaks Induced in Human Cells by 6 Current Pesticides: Intercomparisons and Influence of the ATM Protein
por: Sonzogni, Laurène, et al.
Publicado: (2022)

DNA breaks induced by iodine-containing contrast medium in radiodiagnostics: a problem of tungsten?
por: Ferlazzo, Mélanie L., et al.
Publicado: (2018)

Image-Guided Robotic Stereotactic Radiation Therapy with Fiducial-Free Tumor Tracking for Lung Cancer
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2012)

Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer)
por: Lesueur, Paul, et al.
Publicado: (2018)

Stereotactic Re-irradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: Preliminary Results
por: Olivier, Jonathan, et al.
Publicado: (2019)

Studies of Intra-Fraction Prostate Motion During Stereotactic Irradiation in First Irradiation and Re-Irradiation
por: Taillez, Alexandre, et al.
Publicado: (2021)

Hypofractionated stereotactic radiotherapy for large arteriovenous malformations
por: Wang, Huan-Chih, et al.
Publicado: (2012)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Prognostic Factors of Local Control, Overall Survival, and Toxicity
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2013)

Stereotactic Body Radiation Therapy for the Management of Hepatocellular Carcinoma: Efficacy and Safety
por: Roquette, Isaure, et al.
Publicado: (2022)

A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases
por: Fumagalli, Ingrid, et al.
Publicado: (2012)

Prognostic factors affecting local control of hepatic tumors treated by stereotactic body radiation therapy
por: Dewas, Sylvain, et al.
Publicado: (2012)

The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases
por: Gutschenritter, Tyler, et al.
Publicado: (2020)

Clinical evaluation of an endorectal immobilization system for use in prostate hypofractionated Stereotactic Ablative Body Radiotherapy (SABR)
por: Nicolae, Alexandru, et al.
Publicado: (2015)

Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
por: Shibamoto, Yuta, et al.
Publicado: (2016)

Intracranial chordoma: radiosurgery, hypofractionated stereotactic radiotherapy and treatment outcomes
por: Napieralska, Aleksandra, et al.
Publicado: (2021)

Evaluation of efficacy and safety of robotic stereotactic body radiosurgery and hypofractionated stereotactic radiotherapy for vertebral metastases
por: Księżniak-Baran, Dorota, et al.
Publicado: (2015)

A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the CKNO-PRO Trial
por: Pasquier, David, et al.
Publicado: (2023)

Harmonization of dose prescription for lung stereotactic radiotherapy
por: Beldjoudi, Guillaume, et al.
Publicado: (2022)

Stereotactic irradiation of non-small cell lung cancer brain metastases: evaluation of local and cerebral control in a large series
por: Fessart, Etienne, et al.
Publicado: (2020)

Reproducibility and geometric accuracy of the fixster system during hypofractionated stereotactic radiotherapy
por: Lindvall, Peter, et al.
Publicado: (2008)

Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma
por: Vordermark, Dirk, et al.
Publicado: (2005)

Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters
por: Jiang, Xue-song, et al.
Publicado: (2012)

Cone-beam computed tomography in hypofractionated stereotactic radiotherapy for brain metastases
por: Ingrosso, Gianluca, et al.
Publicado: (2012)

Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinoma
por: Kim, Hun Jung, et al.
Publicado: (2016)

Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience
por: Ciammella, Patrizia, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_sj037qukekf5bnretf7mfov8em